TIGIT and multiple sclerosis: Previous studies report that TIGIT+ Tregs selectively suppress Th1 and Th17 responses (52) and TIGIT signaling counteracts IFN-γ production in Th1 Treg cells which are dysregulated in multiple sclerosis (53).